From the various clinical studies with Spirulina supplementation in various disorders it can be concluded that:
• Spirulina supplementation in T2DM patients resulted in significant reduction in fasting and postprandial blood glucose, glycated Hb, and also helped in lowering the atherogenic lipid parameters.
• The positive results obtained in protein status, pulmonary function and IgE status in Spiralina-supplemented asthma patients strongly suggests that Spirulina can be introduced along with medicine as a therapeutic and dietary supplement in the treatment of asthmatics.
• Remarkable improvement in the prognosis of nephrotic syndrome patients with Spirulina supplementation substantiates the role of Spirulina as a health product in the management of nephrotic syndrome.
• Beneficial effect of Spirulina was also seen among preschool children and adolescent anemic girls whereby it helped in improving the blood hemoglobin levels thereby bringing about a reduction in the prevalence of anemia.
Thus to conclude it can be said that Spirulina with its potential therapeutic properties has been shown to be beneficial in the management of various disorders and may help to optimize health in the long run.
Was this article helpful?